critic
need
advanc
infecti
diagnost
surveil
system
taken
new
urgenc
increas
concern
bioterror
agent
well
natur
pathogen
eg
bacillu
anthraci
coronaviru
avian
influenza
viru
dna
microarray
platform
simultan
detect
character
mani
differ
type
human
pathogen
caus
similar
symptom
provid
consider
potenti
medic
use
nation
defens
purpos
bodrossi
sessitsch
cleland
et
al
dna
microarray
simultan
interrog
hundr
thousand
immobil
probe
dna
oligonucleotid
probe
provid
singl
queri
known
sequenc
uniqu
organ
trait
use
dna
microarray
pathogen
detect
gain
promin
lead
explos
growth
research
bryant
et
al
effect
use
microarray
pathogen
detect
requir
optim
sever
factor
sampl
amplif
probe
specif
interpret
strategi
order
obtain
unambigu
reproduc
result
striebel
et
al
major
technic
hurdl
limit
straightforward
applic
dna
microarray
broadspectrum
pathogen
diagnost
requir
specif
amplif
reagent
protocol
primarili
pcr
amplifi
chosen
target
prior
microarray
hybrid
et
al
striebel
et
al
random
amplif
strategi
conjunct
spot
microarray
develop
use
multipl
round
amplif
detect
broad
spectrum
pathogen
complex
biolog
sampl
wang
et
al
vora
et
al
anoth
hurdl
use
spot
microarray
design
specif
oligonucleotid
probe
pathogen
identif
depend
assumpt
regard
target
sequenc
composit
long
oligonucleotid
probe
use
prior
studi
disadvantag
decreas
specif
threshold
differenti
sequenc
similar
make
necessari
target
multipl
marker
reli
hybrid
pattern
pathogen
identif
lead
unquantifi
error
bodrossi
sessitsch
nevertheless
microarray
provid
success
platform
screen
larg
number
pathogen
viral
famili
level
via
use
highli
conserv
hybrid
mismatchtoler
oligonucleotid
wang
et
al
wang
et
al
addit
problem
format
crosshybrid
occur
two
sequenc
share
high
degre
similar
kothap
et
al
care
data
interpret
need
differenti
subtyp
pathogen
use
spot
microarray
hybrid
pattern
approach
produc
direct
genom
sequenc
output
requir
manual
isol
convent
dna
sequenc
captur
pathogen
target
wang
et
al
thu
obviou
incorpor
concept
broadspectrum
diagnost
devic
hundr
pathogen
microorgan
variant
requir
signific
reduct
design
process
analysi
step
exponenti
increas
avail
microbi
sequenc
make
possibl
envis
use
direct
sequenc
routin
pathogen
diagnost
surveil
howev
requir
pathogen
sequenc
inform
rapidli
obtain
resequenc
microarray
use
tile
set
probe
either
contain
one
perfectli
match
three
mismatch
probe
per
base
strand
target
gene
hacia
arraybas
format
combin
specif
pcr
proven
ideal
singl
nucleotid
polymorph
snp
genotyp
phylogenet
analysi
kozal
et
al
gingera
et
al
k
wilson
et
al
w
wilson
et
al
wong
et
al
sever
type
variat
especi
insertiondelet
frequent
multipl
substitut
pathogen
sequenc
perturb
hybrid
pattern
approach
use
differenti
measur
specif
pathogen
hybrid
pattern
identifi
individu
sequenc
variant
identif
requir
priori
knowledg
differenti
hybrid
pattern
empir
determin
control
experi
even
control
experi
carri
characterist
conserv
hybrid
pattern
alway
occur
highli
divers
pathogen
target
obtain
clinic
specimen
studi
overal
object
demonstr
util
resequenc
microarray
approach
simultan
detect
respiratori
pathogen
format
use
clinic
environ
without
requir
design
pathogenspecif
pcr
primer
w
fix
hybrid
pattern
gingera
et
al
chose
use
customdesign
affymetrix
resequenc
respiratori
pathogen
microarray
rpm
furthermor
develop
method
automat
assembl
incomplet
disconnect
pathogen
sequenc
data
cumul
sequenc
amen
similaritybas
eg
basic
local
align
search
toolblast
altschul
et
al
identif
combin
resequenc
microarray
applic
statist
metric
raw
output
assay
allow
unambigu
reproduc
sequencebas
pathogen
identif
clinic
specimen
result
demonstr
feasibl
approach
correct
speciesand
strainlevel
identif
unambigu
statist
interpret
adenoviru
influenza
strain
clinic
relev
sensit
level
report
suggest
feasibl
use
technolog
broadspectrum
surveil
respiratori
pathogen
provid
new
inform
incid
pathogen
coinfect
accuraci
rpm
chip
sequencespecif
pathogen
detect
valid
use
clinic
andor
control
laboratori
sampl
sampl
amplifi
either
pathogenspecif
pcr
random
amplif
strategi
hybrid
array
test
whether
prototyp
tile
region
could
use
identif
broad
number
variant
without
reli
predetermin
hybrid
pattern
use
febril
respiratori
ill
fri
caus
adenovirus
hadv
model
system
capabl
rpm
discrimin
hadv
serotyp
test
interrog
degener
pcr
amplicon
lin
et
al
differ
hadv
strain
fulli
sequenc
member
epidem
outbreak
surveil
eo
consortium
amplicon
hybrid
chip
gda
softwar
affymetrix
inc
use
gener
sequenc
call
compar
respect
hybrid
intens
paramet
nucleotid
base
call
algorithm
cutler
et
al
within
gda
set
allow
maximum
number
base
call
permiss
base
call
algorithm
set
supplement
data
gener
primari
nucleotid
sequenc
produc
filter
subject
sequenc
similar
search
use
respiratori
pathogen
identifi
repi
softwar
develop
group
report
examin
result
repi
count
sampl
posit
specif
pathogen
least
one
subsequ
pathogen
prototyp
tile
region
produc
blast
return
return
lowest
expect
e
valu
match
specif
pathogen
evalu
multipl
record
score
indic
differ
strain
gener
ambigu
strain
identif
could
still
unambigu
serotyp
level
approach
allow
one
individu
subsequ
use
pathogen
identif
without
reli
design
strainspecif
probe
hybrid
pattern
recognit
gingera
et
al
permit
highli
variabl
hybrid
pattern
produc
order
sequenc
rank
result
demonstr
tile
region
rpm
differenti
variou
friassoci
hadv
strain
tabl
prove
prototyp
tile
region
use
identifi
broad
rang
variant
strainlevel
identif
obtain
case
except
subgroup
strain
identifi
belong
subgroup
similar
fashion
remain
tile
region
rpm
success
valid
except
west
nile
viru
valid
test
control
laboratori
strain
tabl
supplement
data
use
except
case
influenza
viru
tile
region
instead
total
rna
obtain
patient
infect
influenza
southeast
asia
use
valid
tile
region
tabl
pathogen
valid
least
three
independ
amplif
result
reproduc
reveal
prototyp
refer
region
exhibit
littl
discern
crosshybrid
interfer
one
pathogen
one
other
never
caus
erron
identif
similar
result
obtain
either
specif
random
amplif
data
shown
fals
posit
obtain
due
microarray
base
call
analysi
error
resequenc
ie
genotyp
applic
affymetrix
genechip
system
attend
protocol
optim
highli
accur
detect
snp
use
specif
pcr
amplif
order
achiev
unbias
pathogen
detect
rpm
random
amplif
strategi
develop
rather
random
amplif
protocol
previous
develop
requir
multipl
amplif
step
wang
et
al
vora
et
al
protocol
remov
human
nucleic
acid
na
first
use
singl
amplif
step
develop
protocol
combin
backend
autom
sequenc
similar
search
simplifi
microarraybas
diagnost
strategi
process
allow
sensit
unbias
microarraybas
identif
respiratori
tract
pathogen
fig
two
common
respiratori
viral
pathogen
known
caus
fri
outbreak
militari
train
facil
dna
viru
influenza
viru
negativestrand
rna
viru
use
test
process
clinic
relev
system
assay
sensit
specif
assess
base
clinic
nasal
wash
throat
swab
sampl
obtain
naval
health
research
center
nhrc
san
diego
ca
lackland
air
forc
base
san
antonio
tx
enhanc
detect
sensit
separ
human
dna
rna
subtract
pathway
coupl
random
na
amplif
develop
dna
target
eg
isol
total
na
nasal
wash
throat
swab
specimen
first
subject
mcrbc
enzymat
digest
methyl
cpg
site
pann
et
al
reduc
human
genom
dna
manag
size
kb
follow
subtract
repetit
sequenc
use
human
dna
fig
remain
dna
subject
wholegenom
amplif
lovmar
et
al
routin
allow
full
partial
detect
hexon
fiber
gene
target
concentr
start
clinic
sampl
rna
pathogen
target
nonhuman
rna
speci
enrich
captur
remov
human
rrna
rrna
polyadenylatedmrna
microbenrich
ambion
inc
subsequ
amplif
enrich
rna
use
modifi
random
revers
transcript
pcr
previous
describ
method
wang
et
al
wang
et
al
kessler
et
al
led
reproduc
detect
sensit
plaqueform
influenza
viru
previous
frozen
nasal
wash
specimen
comparison
detect
sensit
without
subtract
adenoviru
influenza
viru
plaqueform
start
clinic
sampl
combin
human
na
background
subtract
random
amplif
remain
na
clinic
sampl
greatli
increas
detect
sensit
without
multipl
amplif
step
success
proofofconcept
experi
test
capabl
rpm
discrimin
pathogen
figur
show
raw
data
imag
gener
hybrid
prototyp
strain
wholegenom
random
amplicon
rpm
signific
crosshybrid
result
sampl
show
follow
multipl
access
number
tie
highest
probabl
score
found
match
sampl
indic
subgroup
adenoviru
member
base
call
outsid
tile
region
similarli
raw
data
imag
gener
hybrid
randomli
amplifi
na
clinic
nasal
wash
sampl
identifi
influenza
viru
type
fig
addit
accur
identifi
singl
pathogen
speci
figur
provid
exampl
anoth
benefit
use
protocol
pathogen
detectionth
abil
detect
coinfect
without
use
refer
control
hybrid
comparison
throat
swab
specimen
collect
symptomat
patient
previous
vaccin
shown
harbor
adenovirusspecif
dna
hybrid
specif
prototyp
region
result
analysi
subsequ
gene
fig
indic
presenc
expect
howev
analysi
subsequ
prototyp
region
reveal
subsequ
match
fig
annot
genom
sequenc
genbank
access
number
similar
result
also
obtain
hexon
fiber
gene
prototyp
region
strongli
suggest
presenc
two
adenovir
speci
find
verifi
sever
independ
convent
molecular
adenoviru
identif
method
gj
vora
b
lin
k
gratwick
ce
meador
c
hansen
c
tibbett
da
stenger
irvin
seto
purkayastha
et
al
prep
influenza
viru
strain
import
distinguish
subtyp
also
identifi
differ
associ
signific
shift
subtyp
year
year
accuraci
microarray
identifi
variat
demonstr
influenza
viru
fig
visual
examin
hybrid
amplicon
clinic
sampl
influenza
viru
hemagglutinin
gene
prototyp
sequenc
correctli
identifi
presenc
influenza
viru
sequencebas
repi
analysi
reveal
ident
viru
nearli
ident
subtyp
anoth
strain
circul
flu
season
anew
vaccin
strain
identif
correspond
identif
made
base
sequenc
obtain
use
convent
dna
sequenc
everi
clinic
sampl
identifi
influenza
viru
whose
sequenc
obtain
use
convent
dna
sequenc
method
two
method
identifi
strain
correspond
data
shown
accuraci
sequenc
inform
produc
rpm
typinglevel
identif
establish
affect
either
reduc
stringenc
set
affymetrix
basecal
algorithm
method
use
randomli
amplifi
pathogen
target
clinic
specimen
detail
analysi
accuraci
microarray
specif
strain
identif
compar
convent
sequenc
sever
influenza
b
strain
cover
separ
paper
wang
et
al
preliminari
clinic
studi
perform
sampl
collect
nhrc
eo
team
lackland
air
forc
base
comparison
two
amplif
strategi
random
amplif
multiplex
pcr
employ
microarray
set
clinic
sampl
shown
tabl
influenza
viru
cultureposit
nasal
wash
six
throat
swab
sampl
test
use
random
multiplex
pcr
amplif
method
use
multiplex
pcr
sampl
correctli
diagnos
comparison
cultur
method
use
random
amplif
sampl
identifi
rpm
identifi
sampl
subtyp
also
differenti
sampl
demonstr
potenti
resequenc
microarray
use
hemagglutinin
gene
sequenc
exampl
sampl
collect
novemb
surpris
see
sampl
collect
geograph
region
season
usual
contain
similar
strain
similar
blast
search
result
observ
sequenc
gener
sampl
random
amplif
multiplex
pcr
done
suggest
random
amplif
method
correspond
well
multiplex
pcr
tabl
addit
assay
correctli
identifi
type
clinic
sampl
coinfect
pyogen
compar
tradit
cultur
detect
method
tabl
two
clinic
sampl
test
neg
use
convent
method
also
pathogen
detect
test
microarray
data
shown
result
demonstr
abil
microarraybas
diagnost
correctli
identifi
type
clinic
relev
hadv
influenza
strain
manner
consist
convent
cultur
detect
addit
studi
carri
clinic
sampl
collect
nhrc
assess
util
microarraybas
diagnost
respiratori
pathogen
detect
sampl
n
consist
neg
posit
throat
swab
viral
transport
medium
subject
clinic
document
respiratori
ill
site
collect
sampl
test
use
convent
method
sent
us
code
fashion
test
experi
conduct
two
independ
investig
sampl
ident
reveal
result
assess
final
comparison
demonstr
complet
concord
method
convent
method
sampl
tabl
clinic
sampl
neg
sampl
failur
detect
pathogen
present
two
sampl
test
three
influenza
sampl
first
studi
five
fals
neg
probabl
due
insuffici
sensit
current
method
howev
falseposit
result
obtain
due
microarray
base
call
analysi
error
futur
effort
focu
improv
assay
sensit
demonstr
straightforward
approach
capit
everincreas
avail
pathogen
nucleic
acid
sequenc
provid
strainlevel
inform
without
reli
fix
hybrid
pattern
reli
specif
oligonucleotid
sequenc
amplifi
specif
target
approach
allow
simultan
detect
differenti
common
circul
respiratori
pathogen
clinic
relev
sensit
level
also
enabl
us
identifi
coinfect
rare
encount
typic
unexpect
pathogen
technolog
requir
priori
knowledg
differenti
hybrid
pattern
pathogen
identif
thu
necessari
build
databas
refer
hybrid
pattern
control
experi
differenti
subtyp
pathogen
also
falseposit
rate
caus
crosshybrid
two
sequenc
share
high
degre
similar
greatli
reduc
approach
experi
valid
tile
sequenc
rpm
falseposit
result
obtain
use
clinic
sampl
misidentif
made
use
control
laboratori
sampl
tabl
presenc
two
coinfect
also
identifi
correctli
strain
level
case
interpret
pathogen
ident
much
straightforward
system
demonstr
remark
low
falseposit
rate
high
specif
system
remain
somewhat
limit
sensit
indic
fals
neg
sensit
current
system
detect
adenoviru
target
concentr
start
clinic
sampl
influenza
viru
plaqueform
use
combin
human
na
background
subtract
random
amplif
remain
na
due
use
specif
primer
exponenti
amplif
pcr
surpris
see
multiplex
pcr
sensit
random
amplif
limit
sensit
result
fals
neg
especi
patient
test
earli
late
infect
pathogen
interest
typic
shed
high
titer
hadv
influenza
viru
futur
work
focu
improv
assay
sensit
use
complet
subtract
background
human
dna
rna
nevertheless
assay
may
still
use
applic
assay
yet
optim
detail
strainlevel
identif
speed
h
cost
per
chip
per
pathogen
speci
rel
desir
rapid
infecti
diseas
diagnost
improv
process
method
lin
et
al
use
next
gener
resequenc
chip
increas
sequenc
content
substanti
decreas
cost
time
comparison
current
state
art
would
requir
multipl
diagnost
test
discern
offend
agent
assay
abl
look
commonli
occur
infecti
agent
also
survey
less
common
pathogen
singl
test
abil
order
singl
assay
effect
differenti
diagnosi
among
major
pathogen
caus
fri
syndrom
increas
number
diagnos
made
far
fewer
assay
public
health
epidem
outbreak
scenario
abil
rapidli
identifi
less
common
pathogen
among
exampl
primari
sequenc
data
gener
hybrid
randomli
amplifi
target
rpm
tile
probe
set
clinic
throat
swab
sampl
nhrc
found
contain
adenovir
coinfect
fig
hybrid
tile
prototyp
sequenc
region
result
identif
wherea
sequenc
gener
via
hybrid
tile
prototyp
sequenc
region
suggest
presenc
b
c
amplicon
gener
clinic
throat
swab
sampl
nhrc
hybrid
influenza
viru
anew
hemagglutinin
gene
prototyp
sequenc
identifi
via
repi
analysi
influenza
viru
singl
nucleotid
differenti
experiment
sequenc
tile
prototyp
sequenc
background
season
fri
enabl
effect
identif
lead
better
respons
natur
occur
epidem
outbreak
even
bioterror
event
inform
combin
clinic
symptom
data
confirmatori
laboratori
test
result
accur
diseas
report
decreas
diseas
exposur
improv
outcom
individu
public
health
viral
agent
caus
infect
respiratori
tract
satisfi
could
detect
type
dna
rna
virus
clinic
sampl
use
random
amplif
method
clinic
relev
sensit
level
couch
et
al
boivin
et
al
success
rpm
alreadi
led
develop
initi
test
rpm
includ
bacteri
viral
speci
futur
work
focu
improv
sensit
assay
speed
order
achiev
highthroughput
capabl
provid
costeffect
diagnost
platform
pathogen
detect
epidem
surveil
rpm
fig
design
primarili
test
hypothesi
singl
tile
region
could
act
prototyp
identif
broad
number
variant
without
reli
predetermin
hybrid
pattern
prototyp
region
select
allow
effici
hybrid
uniqu
identif
subtyp
pathogen
speci
probe
tile
inform
rpm
see
supplement
tabl
two
pathogen
hadv
influenza
viru
treat
much
detail
select
base
upon
recent
outbreak
inform
erdman
et
al
kolavicgray
et
al
thompson
et
al
base
partial
sequenc
hexon
fiber
gene
contain
diagnost
region
adenoviru
serotyp
tile
detect
fricaus
human
adenovirus
similarli
tile
region
influenza
viru
detect
compris
partial
sequenc
hemagglutinin
gene
subtyp
neuraminidas
gene
subtyp
matrix
gene
addit
hadv
influenza
viru
current
rpm
design
permit
discrimin
common
respiratori
pathogen
six
center
diseas
control
prevent
categori
bioterror
pathogen
tabl
known
caus
fri
ie
flulik
symptom
earli
stage
infect
detail
descript
prototyp
field
strain
use
studi
sourc
list
supplement
tabl
throat
swab
collect
molecular
biolog
laboratorynhrc
san
diego
ca
patient
fri
symptom
immedi
place
cryogen
vial
contain
ml
viral
transport
medium
vtm
maintain
viral
particl
transport
nasal
wash
eo
team
lackland
air
forc
base
collect
basic
militari
traine
fri
symptom
instanc
sampl
test
site
collect
use
convent
detect
techniqu
submit
microarraybas
detect
mask
fashion
collect
transport
clinic
sampl
compli
wilford
hall
medic
center
protocol
clinic
investig
nucleic
acid
extract
clinic
sampl
use
masterpur
dna
purif
kit
epicentr
technolog
follow
manufactur
recommend
protocol
slight
modif
omit
rnase
digest
step
inform
consent
obtain
particip
natur
possibl
consequ
studi
explain
beadbas
subtract
step
carri
remov
human
genom
dna
rna
clinic
sampl
human
dna
remov
cot
human
dna
roch
appli
scienc
consist
larg
rapidli
anneal
repetit
element
label
end
perkinelm
life
scienc
inc
termin
transferas
new
england
biolab
inc
extract
na
clinic
sampl
digest
u
mcrbc
new
england
biolab
inc
min
mix
biotinyl
cot
human
dna
reaction
mixtur
brought
final
volum
final
concentr
ssc
sd
reaction
mixtur
incub
min
slowli
cool
incub
h
streptavidinco
magnet
bead
bioclon
inc
ad
mixtur
captur
hybrid
human
dna
enrich
dna
supernat
transfer
fresh
tube
final
dna
precipit
ethanol
subject
random
amplif
procedur
see
human
rna
background
subtract
microbenrich
ambion
inc
kit
use
follow
manufactur
recommend
protocol
rna
precipit
ethanol
subject
random
amplif
procedur
random
amplif
dna
sampl
carri
either
bacteriophag
dna
polymeras
modifi
random
amplif
protocol
previous
publish
paper
wang
et
al
wang
et
al
briefli
dna
amplif
util
bacteriophag
dna
polymeras
random
hexam
perform
accord
instruct
genomiphi
dna
amplif
kit
amersham
bioscienc
corp
dna
amplif
util
modifi
random
amplif
perform
initi
round
dna
synthesi
use
sequenas
version
dna
polymeras
unit
state
biochem
primer
follow
pcr
amplif
primer
e
rna
amplif
viral
sampl
amplifi
modifi
version
random
pcr
protocol
wang
et
al
wang
et
al
kessler
et
al
briefli
total
rna
revers
transcrib
use
primer
superscript
iii
revers
transcriptas
invitrogen
corp
amplifi
pcr
primer
e
random
pcr
reaction
carri
peltier
thermal
mj
research
inc
cycl
sec
sec
sec
sec
final
extens
min
analysi
clinic
specimen
sampl
subject
dna
rna
subtract
amplif
amplifi
product
combin
subject
purif
process
prior
hybrid
rpm
influenza
virus
multiplex
rtpcr
hemagglutinin
neuraminidas
matrix
gene
amplifi
three
set
segmentspecif
primer
hoffmann
et
al
hotstartaq
multiplex
pcr
kit
qiagen
inc
amplif
reaction
carri
peltier
thermal
mj
research
inc
initi
activ
step
min
follow
cycl
sec
sec
sec
final
extens
min
adenoviru
multiplex
pcr
amplif
carri
previous
describ
lin
et
al
microarray
hybrid
process
carri
accord
manufactur
recommend
protocol
affymetrix
inc
scan
gco
softwar
use
reduc
raw
imag
dat
file
simplifi
file
format
cel
file
intens
assign
correspond
probe
posit
final
gda
softwar
use
appli
embed
version
abacu
cutler
et
al
algorithm
produc
estim
correct
base
call
compar
respect
intens
sens
antisens
probe
set
increas
percentag
base
call
adjust
paramet
allow
permiss
base
call
permiss
set
supplement
data
sequenc
base
call
made
tile
region
resequenc
array
export
gda
fastaformat
file
resequenc
pathogen
identif
repi
softwar
develop
design
filter
output
fasta
file
perform
sequenc
similar
search
use
ncbi
blastn
algorithm
algorithm
first
remov
control
sequenc
sinc
intend
indic
correct
oper
specif
design
affymetrix
nonsens
sequenc
therefor
never
relev
return
next
sequenc
evalu
subsequ
usabl
data
return
signific
return
blast
prototyp
tile
sequenc
evalu
start
first
base
call
window
base
long
slide
along
sequenc
search
first
area
score
better
comput
divid
total
valid
base
window
window
length
fig
start
usabl
data
determin
program
move
window
forward
search
locat
window
score
end
subsequ
found
begin
trail
n
trim
subsequ
nucleotid
nt
discard
subsequ
nt
accept
subsequ
nt
length
accept
total
number
n
sequenc
total
subsequ
length
evalu
sequenc
continu
manner
gener
mani
subsequ
need
repres
usabl
data
sequenc
accept
subsequ
queri
public
databas
eg
genbank
nonpubl
sequenc
use
blast
algorithm
output
program
discard
subsequ
return
expect
e
valu
e
display
subsequ
record
evalu
e
raw
blast
output
subsequ
length
databas
identifi
bit
score
evalu
pars
subsequ
save
rank
order
descend
bit
score
fig
addit
number
statist
subsequ
comput
user
analysi
includ
subsequ
percentag
target
sequenc
subsequ
length
number
subsequ
base
call
percentag
subsequ
base
call
repi
java
program
includ
supplement
data
sensit
assess
realtim
pcr
assay
conduct
icycl
instrument
biorad
laboratori
rapid
lightcycl
idaho
technolog
inc
determin
number
adenoviru
genom
sampl
find
patent
pend
softwar
embodi
subject
matter
may
claim
one
patent
applic
andor
issu
patent
pleas
contact
technolog
transfer
offic
us
naval
research
laboratori
interest
obtain
licens
